glp-1 receptors agonist pharmacology Trends in the Development of Receptor Agonists GLP-1 receptor agonists (GLP-1RAs): cardiovascular – Glucagon-Like Peptide-1 Receptor Agonists And

While gene therapy is available for a small subset of patients with specific mutations, developing a therapeutic that broadly targets the cellular stresses that lead to cell death could address a major unmet need

Older patients with depressive and anxiety disorders are susceptible to the age-related acute and chronic brain and physical illnesses, including metabolic, endocrine and neurobiological disorders,1 and are at high risk for cardiovascular, and cerebrovascular comorbidities.2 The significant heterogeneity in geriatric depression results in difficulties in both comparing research findings and identifying biomarkers to establish homogeneous subgroups for depression personalized therapy.3 Since oxidative stress is associated with depression,4 it is reasonable to search for such biomarkers among antioxidant systems, i.e

How does the original GLP-1 discovery differ from today's medications

Herbal GLP-1 patches are said to support weight management due to the presence of the ingredients they hold 3 , 9

More research is required, but this is promising